Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June, 2025 as attched.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ishita Drugs & Industries has submitted a compliance certificate to BSE as required under SEBI's Depositories and Participants Regulations for the quarter ended 30th June 2025. This certificate confirms that all shares held in dematerialized (demat) form are in safe custody with the company's Registrar and Share Transfer Agent. It is a routine regulatory requirement that every listed company must file every quarter. The filing does not involve any change in business operations, capital structure, or shareholder rights. It only affirms that the company's share records are properly maintained with the depository participants.
This is a routine compliance filing with no material impact on the company's financials, operations, or stock price. Shareholders do not need to take any action.